DENALI THERAPEUTICS INC
DNLI·24823R105·US·Common Stock·Healthcare - Biotechnology-13D/G
DNLI (DENALI THERAPEUTICS INC) is held by 142 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($360.8M), BAILLIE GIFFORD & CO ($307.6M), STATE STREET CORP ($181.3M). Net institutional sentiment: Mixed.
142
Holders
(9 Elite)
$3.1B
Total Value
66% (138)
Consensus
91 buying - 47 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 14, 2026 · Activists Aug 4, 2026 · Congress none
InsiderWJWatts Ryan J.Gift 32K shAug 12, 2026
InsiderSOSchuth Alexander O.Sell $72KAug 11, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 148
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer